SYNERGY PHARMACEUTICALS INC Inactive Instrument
Synergy Pharmaceuticals Inc Stock Nasdaq
Equities
US8716393082
Biotechnology & Medical Research
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Managers | Title | Age | Since |
|---|---|---|---|
Stephen Comiskey
PRN | Corporate Officer/Principal | - | 08-06-30 |
Leslie M. Magnus
PRN | Corporate Officer/Principal | - | 14-12-31 |
Synergy Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of novel gastrointestinal (GI) therapies. Its gastrointestinal (GI) platform is based on uroguanylin. Uroguanylin physiologically regulates bowel function, fluid balance, and stool consistency.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.97% | 108B | |
| +10.21% | 105B | |
| +1.57% | 23.46B | |
| -12.77% | 21.72B | |
| -7.05% | 18.64B | |
| -37.64% | 17.45B | |
| -6.50% | 17.19B | |
| +6.00% | 13.99B | |
| +37.20% | 12.53B |
